Briviact® (In Italy: Nubriveo®) (brivaracetam 10Mg/ml) Oral solution: Bottles with narrow neck diameter
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Briviact (in Italy: Nubriveo)
|
| Active substance |
Brivaracetam
|
| Therapeutic area (MeSH) |
Epilepsy
|
| Regulatory outcome |
Maintenance
|
| DHPC type |
Quality defect
|
| Human ATC code |
N03AX23
|
| Dissemination date |
18/12/2021
|